ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 97 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2018. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,000 | -63.0% | 15,064 | -55.5% | 0.00% | – |
| Q3 2021 | $73,000 | -22.3% | 33,825 | +26.2% | 0.00% | – |
| Q2 2021 | $94,000 | -66.4% | 26,807 | +3.8% | 0.00% | -100.0% |
| Q4 2020 | $280,000 | -70.5% | 25,819 | -71.9% | 0.00% | -84.6% |
| Q3 2020 | $948,000 | -26.5% | 92,037 | -17.8% | 0.01% | +62.5% |
| Q4 2019 | $1,290,000 | +17.9% | 111,971 | -44.2% | 0.01% | -20.0% |
| Q3 2019 | $1,094,000 | +559.0% | 200,668 | +1333.3% | 0.01% | +400.0% |
| Q2 2019 | $166,000 | -3.5% | 14,000 | -52.8% | 0.00% | -33.3% |
| Q1 2018 | $172,000 | +48.3% | 29,642 | -6.8% | 0.00% | +50.0% |
| Q3 2017 | $116,000 | +346.2% | 31,800 | +208.6% | 0.00% | +100.0% |
| Q2 2017 | $26,000 | -7.1% | 10,303 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $28,000 | – | 10,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,102,735 | $3,485,000 | 3.61% |
| VHCP Management II, LLC | 280,000 | $885,000 | 0.53% |
| GREAT POINT PARTNERS LLC | 550,116 | $1,738,000 | 0.50% |
| JW Asset Management, LLC | 189,919 | $600,000 | 0.48% |
| DAFNA Capital Management LLC | 140,600 | $444,000 | 0.35% |
| Granite Point Capital Management, L.P. | 186,544 | $589,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 779,926 | $2,465,000 | 0.13% |
| TFS CAPITAL LLC | 159,364 | $504,000 | 0.09% |
| Rhenman & Partners Asset Management AB | 154,006 | $487,000 | 0.09% |
| Numeric Investors LLC | 1,134,931 | $3,586,000 | 0.03% |